Routine compliance filing with no trading implications. Monitor upcoming quarterly results for fundamental business performance indicators.
RDY drugs
RDY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 28 $13.52entry
- T+1 · 6mo ago +0.81%α +0.57% · $13.63
- T+5 · 6mo ago −3.70%α −3.65% · $13.02
- T+20 · 5mo ago +13.76%α +16.90% · $15.38
- T+60 · 3mo ago −9.91%α −11.65% · $12.18
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dr. Reddy's filed its annual Secretarial Compliance Report for FY ended March 31, 2026, certifying compliance with SEBI listing regulations, insider trading rules, and corporate governance standards. The report confirms no material non-compliances, no regulatory actions taken against the company, and no resignation of statutory auditors during the period.
Key Facts
- Annual Secretarial Compliance Report for FY ended March 31, 2026 filed on May 28, 2026
- No non-compliances reported across all SEBI regulations examined
- No actions taken by SEBI or stock exchanges against the company, promoters, directors, or subsidiaries
- No resignation of statutory auditors from the listed entity or material subsidiaries during the review period
- All applicable policies under SEBI regulations adopted and timely updated
- Board performance evaluation conducted as prescribed
- Related party transactions received prior Audit Committee approval
Financial Impact
No financial magnitude, this is a governance compliance certification with no monetary impact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000370 |
| Document: 0001575872-26-000370-index.html | 0001575872-26-000370 |
| Document: 0001575872-26-000370.txt | 0001575872-26-000370 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers